Related Experiment Video

Updated: Aug 9, 2026

Measurement of Chitinase Activity in Biological Samples
03:32

Measurement of Chitinase Activity in Biological Samples

Published on: August 22, 2019

[Butyrylcholinesterase deficiency: how to analyse the cholinesterase activity in small children?]

C Lejus1, O Delaroche, E Trille

  • 1Service d'Anesthésie et de Réanimation Chirurgicale, Hôtel-Dieu-Hôpital Mère-Enfant, CHU de Nantes, 44093 Nantes Cedex 01, France. corinne.lejus@chu-nantes.fr

Annales Francaises D'Anesthesie Et De Reanimation
|April 4, 2006
PubMed

Insights

Prolonged neuromuscular blockade occurred in an infant after succinylcholine. This was due to an atypical cholinesterase variant, highlighting age-specific normal values for children.

Area of Science:

  • Anesthesiology
  • Biochemistry
  • Pediatrics

Background:

  • Succinylcholine is a common muscle relaxant used in anesthesia.
  • Genetic variations in pseudocholinesterase can affect drug metabolism.
  • Pediatric patients may exhibit different physiological responses compared to adults.

Observation:

  • An 18-month-old girl experienced prolonged neuromuscular blockade after a standard dose of succinylcholine.
  • Cholinesterase activity in the patient was within adult normal ranges but lower than in a cohort of children.
  • Familial analysis revealed an atypical pseudocholinesterase variant (AA phenotype).

Findings:

  • The patient's low cholinesterase activity indicated a genetic predisposition to prolonged blockade.
  • The AA phenotype of pseudocholinesterase is associated with reduced drug hydrolysis.
  • Age-specific reference ranges for cholinesterase activity are crucial for pediatric diagnosis.

Implications:

  • This case underscores the importance of considering genetic factors in anesthetic drug response.
  • Accurate diagnosis of pseudocholinesterase variants is vital for patient safety.
  • Establishing age-adjusted normal values for cholinesterase activity is necessary for pediatric care.

More Related Videos

Biochemical Measurement of Neonatal Hypoxia13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Related Concept Videos

Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...